It has long been documented that multiple translocation events, resulting in five described TFE3 gene-fusion products and one TFEB gene fusion product, result in renal cell carcinoma (RCC) (Kauffman et al., 2014). This evidence concerns the gene TFEB and hereditary clear cell renal cell carcinoma.